Latest News - Abbott Laboratories
Top Corporates Hub
Abbott Laboratories
Abbott Laboratories (ABT) Debuts Ensure Max Protein Powder With Creatine And HMB
11.10.2026 00:15
Abbott Laboratories (NYSE:ABT) introduced Ensure Max Protein 3-in-1 Muscle Support, a combined protein, creatine, and HMB powder. The product is NSF certified and targets muscle building, recovery, and preservation for everyday active consumers and athletes. This launch expands Abbott's nutrition portfolio beyond devices and diagnostics into a broader performance-focused supplement offering. The Ensure Max Protein 3-in-1 Muscle Support launch is important, but investors should weigh it...
Abbott (ABT) Stock Could Be 24% Overvalued After Heart Failure News
10.10.2026 08:13
Abbott Laboratories has had a rough year in the market, and the recent product news now puts a sharper spotlight on whether the current share price is properly grounded in the cash the business can generate. With a Discounted Cash Flow (DCF) view available, the question is how the recent market drop lines up with the long term cash flow profile investors are effectively paying for today. Over the past year, Abbott Laboratories shares have fallen 23.1%, which puts recent sentiment and the...
Is it the Right Time to Add Phibro Stock to Your Portfolio?
08.10.2026 16:22
PAHC's Animal Health gains from MFA, vaccine and mineral nutrition growth, but tariffs, costs and currency swings remain key risks to its outlook.
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
08.10.2026 12:30
The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
08.10.2026 12:00
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Senseonics: Eversense 365 Adoption Has To Earn The Valuation
08.10.2026 11:00
Senseonics's Eversense 365 CGM drives sales and margin gains, but adoption, funding, dilution, and valuation risks remain. Click here for more on SENS stock.
Point-of-Care Testing, Falling Prices and PCR Threaten the Immunoassay Lab Model: What Diagnostics Leaders Must Do Next
08.10.2026 10:52
Forecasts by application, technology and care setting show where hospital and outpatient lab spending is shifting, with strategies from 64 players including Roche, Abbott and Siemens Healthineers.Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Impact of Artificial Intelligence" has been added to ResearchAndMarkets.com's offering. The diagnostic industry is entering a
HealthTab™ and HeartEye Open New Referral Pathway into Community Pharmacy
08.10.2026 10:30
VANCOUVER, British Columbia, Oct. 08, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) is pleased to announce that its wholly owned subsidiary, HealthTab Ltd. (“HealthTab”), has completed an integration with HeartEye, a UK provider of AI-based retinal cardiovascular risk assessment. The integration creates a new referral pathway into community pharmacy: people found to be at elevated cardiovascular risk by a HeartEye retinal scan at their optician can be r
Abbott introduces Ensure® Max Protein 3-in-1 Muscle Support, bringing the benefits of a supplement stack into one scoop
07.10.2026 13:00
Muscle support just got simpler. Abbott (NYSE: ABT) today announced the launch of Ensure Max Protein 3-in-1 Muscle Support, a protein powder that combines three key ingredients in one product: protein to help build muscle tissue,† creatine to support exercise recovery‡* and HMB to help preserve muscle.
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, AppFolio, Delek US Holdings, Flutter Entertainment, Honeywell Aerospace, Intuitive Surgical, Marvell, NetApp, and More
07.10.2026 11:59
Pre-Market Stock Futures: Futures are trading lower as today’s oil and interest rates are higher. Baseball legend Babe Ruth was often credited with the saying, “Records are made to be broken,” and Tuesday was one of those days for the stock market. For the second straight day, all major indices ended higher, with only the […]
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
07.10.2026 08:37
Analysts initiated coverage: Neutral on Honeywell Aerospace; Outperform on M&T Bank and SailPoint; Buy on Ambiq Micro; Overweight on Abbott.
Micron To Rally Around 187%? Here Are 10 Top Analyst Forecasts For Wednesday
07.10.2026 08:19
Wall Street analysts revised targets: upgrades for NetApp and Humana; downgrades for PJT Partners; mixed target changes for Redwood, Marvell, Yum and S&P
Disposable Medical Device Market to Reach USD 144.85 Billion by 2030, Growing at a CAGR of 4.9% – MarketsandMarkets™
05.10.2026 14:30
Delray Beach, FL , Oct. 05, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global disposable medical devices market to grow from USD 113.95 billion in 2025 to USD 144.85 billion by 2030, at a CAGR of 4.9% during the forecast period. Market growth is driven by the increasing emphasis on infection prevention and cross-contamination control, rising prevalence of chronic diseases, an aging population, growing surgical volumes, and expanding demand for long-term care, outpatient services, a
Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition
05.10.2026 13:00
Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF System that enable new patient-facing capabilities through the CardioGuide HF App. For the first time, care teams can allow U.S. CardioMEMS patients to view their pulmonary artery pressure (PAP) readings directly on their smartphones, giving them greater insight into their condition and helping them take a more active role in their care.
The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health Companies
05.10.2026 12:29
Healthcare stocks like Abbott Laboratories offer low-beta exposure as rate hike fears and inflation keep markets volatile.
FDA Approves Abbott's Updated CardioMEMS HF System
05.10.2026 09:06
Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF System that enable new patient-facing capabilities through the
Medtronic’s 49-Year Dividend Streak Faces a New Challenge: Is Growth Finally the Real Story?
03.10.2026 11:15
Medtronic has raised its dividend for 49 straight years while the stock quietly lost a fifth of its value, but something in the operating room just changed the entire conversation about why investors should own it.
Abbott Stock And Other Healthcare Dividend Names Built For Supply Chain Shocks
01.10.2026 14:09
Markets are back to obsessing over central bank signals, supply routes and growth downgrades, and that mix is shaking up how investors look at reliable income. When credit feels tighter and headlines keep flagging disruption risks, steady dividend cheques from global healthcare stocks can suddenly look more interesting. This piece walks through three healthcare dividend payers from our screener that appear closely exposed to the latest macro news and explains why their stories might matter to...
In 1935, An Illinois Secretary Bought 3 Shares Of Her Company’s Stock For $180. She Never Sold A Single Share And Always Reinvested Dividends. By The Time She Died In 2010 Her 3 Abbott Shares Had Turned Into $7.2 Million.
01.10.2026 11:21
A secretary at an Illinois pharmaceutical company made a single, unremarkable stock purchase in 1935 and then did almost nothing for the next 75 years. What her college discovered when she died would quietly rewrite everything anyone thought they knew about her.
Abbott Laboratories’ Quarterly Earnings Preview: What You Need to Know
01.10.2026 11:10
Abbott Laboratories is set to report its third-quarter results coming month, with analysts expecting single-digit growth in earnings.